5 • 716 Ratings
🗓️ 14 March 2019
⏱️ 11 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
| 0:00.0 | Hey all, thanks for listening to the Real Life Pharmacology podcast. I'm your host, Eric Christensen pharmacist. |
| 0:07.2 | Today I'm going to cover nitroferantoin, which is a drug that is most commonly used as an antibiotic to treat urinary tract infections. |
| 0:18.9 | Now, it's brand names that it goes by is macrobid or macrodentan. |
| 0:24.2 | And a lot of times people get these brand names mixed up. Really the primary difference is |
| 0:32.6 | in dosing. And if you remember macro bid,, that is twice a day drug. |
| 0:39.8 | So remember BID at the end, and that'll help you remember that that is twice a day versus |
| 0:45.6 | macrodentan, which is generally dosed four times a day. |
| 0:49.5 | MacroBid is that combination of basically the form of the drug, monydrate plus macrocrystals and macrodentin |
| 0:58.2 | is macrocristols only. But a big difference from a patient clinical perspective is macrobid |
| 1:05.7 | is dosed twice a day and that is generally the one that we use most often there. Now how this drug works, |
| 1:13.1 | how this drug helps us, you know, basically kill off bacteria, get rid of that infection, |
| 1:19.3 | is this drug is actually altered by bacterial flavile proteins. And this forms these reactive metabolites, which can ultimately, you know, |
| 1:31.3 | block processes, interfere with processes surrounding bacterial protein synthesis. So kind of a little bit of |
| 1:40.1 | a unique mechanism of action in that respect. |
| 1:47.2 | Now, I mentioned that this drug is certainly used for UTIs, |
| 1:52.9 | and that's really its primary and only major use. Now, one really, really important thing is nitrofrantone is not that active |
| 1:58.2 | against infections that may have systemic involvement. So if you get a situation |
| 2:04.8 | where you've got, you know, maybe more of an upper UTI syndrome or an infection where maybe |
| 2:10.9 | the kidney is involved and you're at risk of systemic infection, this drug may not cover that infection as well. So generally, nitroferentone is going to be |
| 2:22.9 | reserved for lower UTI-type urinary tract infections. So very, very important to remember that if we do have |
| 2:32.3 | some potential to have kind of a systemic infection or a larger |
| 2:36.9 | infection maybe involving the kidneys to likely avoid this drug and use other alternatives. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.